Ipilimumab (IPI) expanded access program (EAP) for patients (pts) with stage III/IV melanoma: Safety data by subgroups Meeting Abstract


Authors: Lawrence, D.; McDermott, D. F.; Hamid, O.; Weber, J. S.; Wolchok, J. D.; Richards, J.; Amin, A.; Bennett, K.; Balogh, A.; Hodi, F. S.
Abstract Title: Ipilimumab (IPI) expanded access program (EAP) for patients (pts) with stage III/IV melanoma: Safety data by subgroups
Meeting Title: 37th Congress of the European Society for Medical Oncology (ESMO)
Journal Title: Annals of Oncology
Volume: 23
Issue: Suppl. 9
Meeting Dates: 2012 Sep 28-Oct 2
Meeting Location: Vienna, Austria
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2012-09-01
Start Page: ix368
Language: English
ACCESSION: WOS:000309409002067
PROVIDER: wos
PUBMED: 23012731
DOI: 10.1093/annonc/mds404
Notes: Meeting Abstract: 1129P -- "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok